TrialAssure, a leading technology provider advancing clinical trial transparency, disclosure, and data sharing, announced ...

Allucent has strategically added executives to its C-suite and is deploying artificial intelligence tools to help small and ...

Claude expands into healthcare and life sciences with HIPAA-ready tools, clinical trial support, and new connectors, ...

Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, confirms the planned announcement of the results from cohort 4 of the randomized, blinded, placebo-controlled ...

Power Medicine, a company revolutionizing oncology drug development, and AdventHealth, a faith-based health system focused on whole-person care, today announced a strategic collaboration to make ...

A clinical research site operator has secured growth equity from a California investment firm and plans to nearly double its ...

The sales agreement contains both financial and data-sharing provisions. PharmAla will seek to ship its LaNeo MDMA Clinical Research Materials to Østfold Hospital Trust at the earliest opportunity, ...

HUTCHMED reported positive Phase 3 trial results for sovleplenib in autoimmune anemia, supporting a planned China drug filing ...

Chinese biopharma Hutchmed today announces that the Phase III registration part of the ESLIM-02 clinical trial of sovleplenib ...

Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, confirms the planned announcement of the results from cohort 4 of the randomized, blinded, placebo-controlled ...

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the enrollment of the first patient in ...

Two Complete Metabolic Responses (CMRs) observed in patients with relapsed/refractory metastatic Ewing sarcoma and one ...